Streetbeat News

Products Services

VKTX

Viking Therapeutics (NASDAQ:VKTX) has seen a mix of bullish and bearish options trading, with a recent trend towards bearish sentiment. Despite this, the stock price is up 5.7% at $89.9. Analysts have varied target prices, with an average of $81.2. The company specializes in biopharmaceutical development for metabolic and endocrine disorders.

Portfolio Pulse from Benzinga Insights

February 28, 2024 | 2:46 pm

GOGO

Gogo Inc (NASDAQ:GOGO) reported a Q4 fiscal 2023 revenue decline of 10% year-on-year to $97.8 million, surpassing the consensus of $96.5 million. EPS was $0.11, aligning with consensus. Service revenue grew 5% Y/Y, while equipment revenue fell 45% Y/Y. Adjusted EBITDA declined 24% Y/Y to $35.1 million. The company anticipates significant improvements with the launch of Gogo Galileo and Gogo 5G, expecting FY24 revenue of $410 million to $425 million. GOGO shares dropped 0.69% in premarket trading.

Portfolio Pulse from Anusuya Lahiri

February 28, 2024 | 2:41 pm

MDXXF

TRUFF

Red Light Holland Corp. (OTCQB:TRUFF) and PharmAla Biotech Holdings (OTC:MDXXF) are collaborating on psilocybin research and product development. Red Light Holland has received a permit allowing CCrest Labs to import 5kg of its natural psilocybin truffles for R&D, aiming to develop clinical-grade psilocybin drug products. The collaboration also includes potential sales agreements for global markets. Additionally, Red Light Holland is expanding its non-psychedelic mushroom business in North America, with plans to build a large production facility in Peterborough, Ontario.

Portfolio Pulse from Lara Goldstein

February 28, 2024 | 2:33 pm

IXHL

Incannex shares are trading higher following the announcement that its Psi-GAD1 trial met its primary endpoint.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 2:28 pm

VANI

Vivani Medical's shares surged following the announcement of positive preclinical data for NPM-115, showcasing weight loss effects. Additionally, the company revealed that semaglutide is the active ingredient in another of its products, NPM-139.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 2:26 pm

SOLUSD

WIF

Dogwifhat (WIF), a Solana-based memecoin, surged 34% to an all-time high of 77 cents with a trading volume of $180.9 million, positioning it fifth among meme coins by market cap. The broader crypto market rally, including Bitcoin surpassing $60,000, contributed to WIF's rise. With predictions of reaching a $1 billion market cap soon and potential listings on centralized exchanges, WIF's performance reflects the growing interest in meme coins. Solana's total value locked also increased, indicating a shift from Ethereum and Bitcoin to altcoins.

Portfolio Pulse from Khyathi Dalal

February 28, 2024 | 2:26 pm

VIRI

Virios Therapeutics, Inc. (VIRI) issued a shareholder letter detailing corporate progress and upcoming milestones for 2024, including a special shareholder meeting for a potential reverse stock split, a 10% salary reduction for employees in exchange for stock options, and updates on their IMC-2 Long-COVID and IMC-1 Fibromyalgia development programs. The letter emphasizes strategic planning, operational expense management, and the advancement of novel antiviral therapies.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 2:21 pm

TU

TELUS has partnered with Vevo to become its direct ad sales representative in Canada, offering advertisers access to Vevo's premium music video content across various platforms. This collaboration aims to provide value for local brands and media agencies by connecting them with audiences through influential music videos, leveraging TELUS' reach in the Canadian market.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 2:18 pm

BITF

BTBT

CLSK

HIVE

HUT

MARA

RIOT

Bitcoin mining stocks such as Marathon Digital Holdings Inc (MARA), Riot Platforms Inc (RIOT), CleanSpark Inc (CLSK), Hut 8 Corp (HUT), HIVE Digital Technologies Ltd (HIVE), Bit Digital Inc (BTBT), and Bitfarms Ltd (BITF) are experiencing gains due to the continued rise in Bitcoin's price, which recently surpassed $60,000. This surge is attributed to increased demand following the approval of spot ETFs and anticipation of the upcoming halving event in April. CleanSpark's recent strong earnings report and the upcoming earnings reports from other miners are also contributing factors.

Portfolio Pulse from Adam Eckert

February 28, 2024 | 2:16 pm

ADIL

Adial Pharmaceuticals Inc (NASDAQ:ADIL) announced the issuance of a new US patent (number 11,905,562) for its lead investigational drug, AD04, targeting the serotonin transporter gene for treating opioid use disorder (OUD). This patent strengthens Adial's portfolio, highlighting AD04's potential in treating OUD and other drug dependencies beyond its initial focus on alcohol use disorder (AUD). The company remains committed to advancing AD04 towards commercialization for AUD and exploring its efficacy for OUD and other indications.

Portfolio Pulse from Vandana Singh

February 28, 2024 | 2:16 pm